Antithrombotic and antiplatelet activity of an organometallic rhodium(I) complex incorporating a substituted thieno‐[2,3‐d]‐pyrimidine ligand: Synthesis, structural characterization, and molecular docking calculations
- 15 February 2021
- journal article
- research article
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 35 (6), e6210
- https://doi.org/10.1002/aoc.6210
Abstract
No abstract availableKeywords
Funding Information
- National and Kapodistrian University of Athens (16672)
This publication has 60 references indexed in Scilit:
- Rhodium(III) and iridium(III) complexes as anticancer agentsInorganica Chimica Acta, 2012
- H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulationsNucleic Acids Research, 2012
- In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombinJournal of Inflammation, 2011
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Synthetic and spectroscopic characterization of Rh(I)-( S )-amino acid complexes with diphosphine and triphosphine ligandsJournal of Coordination Chemistry, 2007
- Non Platinum Metal Complexes as Anti‐cancer DrugsArchiv der Pharmazie, 2007
- A critical account on π–π stacking in metal complexes with aromatic nitrogen-containing ligands †J. Chem. Soc., Dalton Trans., 2000
- Synthesis of thieno[2,3‐d]pyrimidines from 4,6‐dichloropyrimidine‐5‐carbaldehydesJournal of Heterocyclic Chemistry, 1993
- The C-H.cntdot..cntdot..cntdot.O hydrogen bond in crystals: what is it?Accounts of Chemical Research, 1991
- Di‐μ‐Chloro‐Bis(η 4 ‐1,5‐Cyclooctadiene)‐Dirhodium(I)Published by Wiley ,1990